Calyx Chemicals And Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 51.00 Cr
- Paid Up Capital ₹ 2.10 M
- Company Age 39 Year, 1 Month
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 105.01 Cr
- Satisfied Charges ₹ 2,584.83 Cr
- Revenue Growth -23.68%
- Profit Growth -78.91%
- Ebitda -29.84%
- Net Worth -1.27%
- Total Assets -42.02%
About Calyx Chemicals And Pharmaceuticals
Calyx Chemicals And Pharmaceuticals Limited (CCAPL) is a leading Public Limited Indian Non-Government Company incorporated in India on 14 January 1986 and has a history of 39 years and one month. Its registered office is in Thane, Maharashtra, India.
The Corporate was formerly known as Calyx Chemicals And Pharmaceuticals Private Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 51.00 Cr and a paid-up capital of Rs 2.10 M.
The company currently has active open charges totaling ₹105.01 Cr. The company has closed loans amounting to ₹2,584.83 Cr, as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Calyx Chemicals And Pharmaceuticals Limited India is Vasant Jain as CFO. Vasant Jain, Khandu Varal, Sunita Nair, and Three other members serve as directors at the Company.
Company Details
- Location
Thane, Maharashtra, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U24220MH1986PLC038618
- Company No.
038618
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
14 Jan 1986
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
What products or services does Calyx Chemicals And Pharmaceuticals Limited offer?
Calyx Chemicals And Pharmaceuticals Limited offers a wide range of products and services, including Pharma Ingredients & Raw Materials, Anti Infective API, Malaria Medicine, Lumefantrine, Blood Pressure Medicine, Telmisartan Tablets.
Who are the key members and board of directors at Calyx Chemicals And Pharmaceuticals?
Executive Team (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Khandu Varal  | Managing Director | 02-May-2019 | Current |
| Vasant Jain | CFO | 09-Dec-2019 | Current |
Board Members (5)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Vasant Jain | Director and Cfo | 02-May-2019 | Current |
| Sunita Nair | Additional Director | 03-May-2024 | Current |
| Sanket Varal | Director | 05-Dec-2022 | Current |
| Ritik Jain | Director | 05-Dec-2022 | Current |
| Gulab Parwe | Additional Director | 03-May-2024 | Current |
Financial Performance of Calyx Chemicals And Pharmaceuticals.
Calyx Chemicals And Pharmaceuticals Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 23.68% decrease. The company also saw a substantial fall in profitability, with a 78.91% decrease in profit. The company's net worth dipped by a decrease of 1.27%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Calyx Chemicals And Pharmaceuticals?
In 2023, Calyx Chemicals And Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Topnotch Chemicals Pvt LtdVasant Jain and Khandu Varal are mutual person
N R Agarwal Industries LimitedSunita Nair is a mutual person
Ruso Pharma Private LimitedVasant Jain, Khandu Varal and 2 more are mutual person
- Amret Life Science Private Limited
Vasant Jain and Khandu Varal are mutual person
Charges (Loans)
₹105.01 Cr
₹2,584.83 Cr
Charges Breakdown by Lending Institutions
- Hdfc Bank Limited : 105.00 Cr
- Abhyudaya Co-Operative Bank Limited : 0.01 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 10 Jan 2023 | Hdfc Bank Limited | ₹105.00 Cr | Open |
| 27 Jul 2021 | Abhyudaya Co-Operative Bank Limited | ₹0.10 M | Open |
| 09 Jan 2020 | Abhyudaya Co-Operative Bank Limited | ₹60.00 Cr | Satisfied |
| 02 Jan 2020 | Others | ₹1.01 Cr | Satisfied |
| 21 Dec 2019 | Others | ₹1.00 Cr | Satisfied |
How Many Employees Work at Calyx Chemicals And Pharmaceuticals?
Unlock and access historical data on people associated with Calyx Chemicals And Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Calyx Chemicals And Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Calyx Chemicals And Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
